Observing Kawasaki disease in European and North Indian children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on Kawasaki disease (KD), which is a leading cause of acquired heart disease in children. It aims to identify patients who are resistant to standard treatment with intravenous immunoglobulin (IVIG) by utilizing scoring systems developed in previous studies. The study will assess the effectiveness of these scoring systems in predicting treatment resistance across different ethnic populations, particularly in European and North Indian cohorts. By understanding the variations in treatment response, the study seeks to improve initial therapy strategies for KD patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged less than 18 years at diagnosis
* Diagnosis of KD according to the AHA criteria

Exclusion Criteria:

* Patients who do not meet the criteria for KD
* Patients for which an alternative infectious diagnosis was not investigated and/or excluded.

Where it's running

• Universidade Federal do Rio de Janeiro
  Rio de Janeiro, Brazil Recruiting
• Children's Hospital Zagreb
  Zagreb, Croatia Recruiting
• University Hospital Centre Zagreb, University School of Medicine
  Zagreb, Croatia Recruiting
• Postgraduate Institute of Medical Education and Research
  Chandigarh, India Recruiting
• Institute of Child Health
  Kolkata, India Recruiting
• ASST Papa Giovanni XXIII
  Bergamo, Italy Recruiting

Study contacts

• Study coordinator: Gabriele Simonini
• Email: gabriele.simonini@meyer.it
• Phone: 3297973141

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Atorvastatin in Chinese children with Kawasaki disease and coronary artery abnormalities

  This phase 3 study tests whether atorvastatin is safe and helpful for children with Kawasaki disease who have coronary artery abnormalities.

  Recruiting Phase 3 Children's Hospital of Fudan University · Shanghai · NCT07530640

• Kawasaki MATCH decision support for suspected Kawasaki disease

  This study will test a machine-learning tool called Kawasaki MATCH to help providers decide if febrile children might have Kawasaki disease.

  Recruiting University of California, San Diego · San Diego, California · NCT07291245

• Cardiovascular health in children and young adults with chronic conditions

  This project will see if children and young adults (ages 6-25) with chronic health conditions show early signs of aging in large and small blood vessels using noninvasive imaging and clinical tests.

  Recruiting Semmelweis University · Budapest and 2 other locations · NCT07086989

• Analyzing Rivaroxaban in Chinese Children with Kawasaki Disease

  This study is testing how well the blood thinner rivaroxaban works in children with Kawasaki disease who have serious heart problems.

  Recruiting Children's Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT06993636

• Optimizing Rivaroxaban Dosing for Children with Giant Coronary Aneurysms After Kawasaki Disease

  This study is testing a new way to dose a blood thinner called rivaroxaban for Chinese children with giant coronary aneurysms after Kawasaki disease to see if it helps prevent heart problems.

  Recruiting Phase 4 Children's Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT06978439

• Rivaroxaban for children over 2 with giant coronary artery aneurysms after Kawasaki disease

  This trial will test whether rivaroxaban given with an antiplatelet medicine is a safe and practical alternative to warfarin for preventing clots in children aged 2 and older with giant coronary artery aneurysms after Kawasaki disease.

  Recruiting Phase 4 Children's Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT05643651

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.